JogoHealth, Inc.
Formerly Neural Therapeutics, Inc.
Funding rounds
4 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
JogoHealth, Inc. reported revenue of $274,267 for its most recent fiscal year (filed Apr 2025), up from $253,476 the year before.
SEC Form C/A · Apr 2025
Net loss for the same year: $2.53 million.
SEC Form C/A · Apr 2025
JogoHealth, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2025).
SEC Form D · Jul 2025
The industry group it chose in its notices: Other Health Care.
SEC Form D · Jul 2025
In its own words
How the company describes itself to search engines on its website, word for word.
“JOGO Health is a digital neurology platform that helps patients receive comprehensive care for neurological, chronic pain, neuromuscular, neuro pelveology, and neuro gastroenterology conditions.”
As of Nov 15, 2026
Products and services#
No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.
Investors#
No investor of JogoHealth, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Sanjai Murali | Executive officer | Jul 2025 |
| Siva Nadarajah | Executive officer | Jul 2025 |
| Ari Bousbib | Director | Jul 2025 |
| Sanjai Murali | Director | Jul 2025 |
| Siva Nadarajah | Director | Jul 2025 |